Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
Conditions: HPV Positive Oropharyngeal Squamous Cell Carcinoma; HIV-1-infection; HPV Infection Interventions: Biological: 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58); Other: Saline Placebo Sponsors: Weill Medical College of Cornell University; H. Lee Moffitt Cancer Center and Research Institute; University of Sao Paulo; University of Puerto Rico; Mexican National Institute of Public Health; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials